Prof. Farahnak Assadi

fassadi@rush.edu


1725 W Harrison St Ste 710

Chicago, IL 60612


312-560-0477

 

 

Professional Biography:

Professor Farahnak Assadi, MD is a pediatric nephrology specialist in Chicago, IL and has been practicing for 49 years. He graduated from Tehran University Of Medical Sciences, Faculty Of Medicine in 1969 and specializes in pediatric nephrology.

He is now the director of Section Pediatric Nephrology at Rush University Medical Center.

On Nevember, 2018 Prof. Assadi was presented with the TUMS Distinguished Visiting Professor Title for the duration of 2018-2021 by Pediatrics Department of TUMS School of Medicine.

Recent Publications:

  • Assadi F. Hyperuricemia: a warning sign of future cardiovascular event and cchronic kidney disease. J Nephropharmacol. 2017 (in press)

  • Kelishadi R, Qorbani M, Assadi F, Motlag ME, Djalalinia S, Ziaodini S, et al. Glomerular hyperfiltration as predictor of cardiometabolic risk factor among children and adolescents: The CASPIAN-V Study. Pediatrics and Neonatalogy (2017)

  • Mazaheri M, Assadi F. Simplified algorithm for evaluation of asymptotic Proteinuria: how should a primary care approach? Int J Prev Med. 2017 (in press)

  • Assadi F. Strategies for preventing catheter-associated urinary tract infection. Int J Prev Med. 2017 (in press)

  • Assadi F, Moghtaderi M, Preventive kidney stones: continue medical education. Int J Prev Med 2017; IP:108.52.155.186. doi10.4103/ijpvm.IJPVM_17_17

  • Assadi F. Value of fractional excretion of urate in differential diagnosis of hyponatremia. J renal Endocrinol 2017;3:208.

  • Assadi F. Passive leg Raising: simple and reliable technique to avoid fluid over load in critical ill patients with circulatory failure. Int J Prev Med 2017;8:48. doi:10.4103/ijpvmjournal.ijpvm_11_17

  • Assadi F, Ghane Sharbaf F. KIM-1 as a potential biomarker of acute renal injury in after circulatory collapse in children. Pediatr Emerg Care. 2016 (Epub ahead of print)

  • Assadi F, Ghane Sharbaf F. Practical considerations to drug dosing in children with acute kidney injury. J Clin Pharmaco. 2016, 56(4):399-407, doi: 10:1002/jcph.636/